SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE PATIENT CLINICAL FACTORS DELAY REASON
The PATIENT clinical factors which resulted in the Systemic Anti-Cancer Therapy Drug Cycle being delayed.
Description
The PATIENT clinical factors which resulted in the Systemic Anti-Cancer Therapy Drug Cycle being delayed.
SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE PATIENT CLINICAL FACTORS DELAY REASON is recorded where the SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE DELAY REASON National Code is ' PATIENT (Clinical) factors' .
National Codes
| Code | Description |
|---|---|
| 1 | Genomics, for example Dihydropyrimidine Dehydrogenase (DPD) enzyme variant |
| 2 | Frailty |
| 3 | Comorbidities |
| 8 | Other (not listed) |
Where Used
| Type | Link | How used |
|---|---|---|
| Class | CLINICAL INTERVENTION | has an attribute SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE PATIENT CLINICAL FACTORS DELAY REASON of type SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE PATIENT CLINICAL FACTORS DELAY REASON |
| Data Element | SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE PATIENT CLINICAL FACTORS DELAY REASON | references in description SYSTEMIC ANTI-CANCER THERAPY DRUG CYCLE PATIENT CLINICAL FACTORS DELAY REASON |